EXH-001

N/A

Report date: 2025/01/26 19:33:10

Base Information

Drug NameEXH-001
Drug Alias NameAAV9-hMMP-3 gene therapy (Exhaura/Trinity College Dublin/Virscio)MMP-3 gene therapy (Exhaura/Trinity College Dublin/Virscio)human matrix metalloproteinase -3 gene therapy (Exhaura/Trinity College Dublin/Virscio)EXH-001
ClassificationBiologics
Mechanisms of ActionMatrix metalloproteinase 3 stimulants
TargetsMatrix metalloproteinase 3
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrinity College Dublin
China Registration ClassN/A

Develop Information

Active CompaniesExhaura LtdVirscioTrinity College Dublin
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A